Patents by Inventor Brian Erich Caplin

Brian Erich Caplin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190271036
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Application
    Filed: May 17, 2019
    Publication date: September 5, 2019
    Applicant: XCR Diagnostics, Inc.
    Inventor: Brian Erich CAPLIN
  • Patent number: 10337056
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: July 2, 2019
    Inventor: Brian Erich Caplin
  • Publication number: 20170226576
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Application
    Filed: April 21, 2017
    Publication date: August 10, 2017
    Applicant: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Patent number: 9670531
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: June 6, 2017
    Assignee: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Publication number: 20160230218
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Application
    Filed: April 26, 2016
    Publication date: August 11, 2016
    Applicant: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Patent number: 9353408
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: May 31, 2016
    Assignee: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Publication number: 20150376689
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Application
    Filed: August 13, 2015
    Publication date: December 31, 2015
    Applicant: FLUORESENTRIC, INC
    Inventor: Brian Erich Caplin
  • Patent number: 9139882
    Abstract: Provided herein are methods for assaying a biological sample for microorganisms having drug resistant and/or drug sensitive phenotypes, wherein the methods are capable of detecting resistant and sensitive phenotypes associated with known and/or unknown mutations. In some aspects, methods are provided for detecting drug resistant Myobacterium tuberculosis (MTb), including multi-drug resistant MTb, wherein drug resistance is associated with one or more novel mutations. Also provided are systems, kits, and compositions related to such methods.
    Type: Grant
    Filed: November 22, 2010
    Date of Patent: September 22, 2015
    Assignee: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Publication number: 20110143357
    Abstract: Provided herein are methods for assaying a biological sample for microorganisms having drug resistant and/or drug sensitive phenotypes, wherein the methods are capable of detecting resistant and sensitive phenotypes associated with known and/or unknown mutations. In some aspects, methods are provided for detecting drug resistant Myobacterium tuberculosis (MTb), including multi-drug resistant MTb, wherein drug resistance is associated with one or more novel mutations. Also provided are systems, kits, and compositions related to such methods.
    Type: Application
    Filed: November 22, 2010
    Publication date: June 16, 2011
    Applicant: SIGNAL DIAGNOSTICS
    Inventor: Brian Erich Caplin
  • Patent number: 7838235
    Abstract: Provided herein are methods for assaying a biological sample for microorganisms having drug resistant and/or drug sensitive phenotypes, wherein the methods are capable of detecting resistant and sensitive phenotypes associated with known and/or unknown mutations. In some aspects, methods are provided for detecting drug resistant Myobacterium tuberculosis (MTb), including multi-drug resistant MTb, wherein drug resistance is associated with one or more novel mutations. Also provided are systems, kits, and compositions related to such methods.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: November 23, 2010
    Assignee: Signal Diagnostics
    Inventor: Brian Erich Caplin
  • Publication number: 20090075269
    Abstract: Provided herein are methods for assaying a biological sample for microorganisms having drug resistant and/or drug sensitive phenotypes, wherein the methods are capable of detecting resistant and sensitive phenotypes associated with known and/or unknown mutations. In some aspects, methods are provided for detecting drug resistant Myobacterium tuberculosis (MTb), including multi-drug resistant MTb, wherein drug resistance is associated with one or more novel mutations. Also provided are systems, kits, and compositions related to such methods.
    Type: Application
    Filed: March 28, 2008
    Publication date: March 19, 2009
    Inventor: Brian Erich Caplin